Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 6
2022 7
2023 7
2024 9
2025 14
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Russell MD, Stovin C, Alveyn E, Adeyemi O, Chan CKD, Patel V, Adas MA, Atzeni F, Ng KKH, Rutherford AI, Norton S, Cope AP, Galloway JB. Russell MD, et al. Among authors: adas ma. Ann Rheum Dis. 2023 Aug;82(8):1059-1067. doi: 10.1136/ard-2023-224049. Epub 2023 May 29. Ann Rheum Dis. 2023. PMID: 37247942 Free PMC article.
The safety of JAK-1 inhibitors.
Clarke B, Yates M, Adas M, Bechman K, Galloway J. Clarke B, et al. Among authors: adas m. Rheumatology (Oxford). 2021 May 5;60(Suppl 2):ii24-ii30. doi: 10.1093/rheumatology/keaa895. Rheumatology (Oxford). 2021. PMID: 33950230 Free PMC article. Review.
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study.
Bechman K, Russell MD, Biddle K, Gibson M, Adas M, Yang Z, Patel S, Dregan A, Walsh S, Brex P, Patel A, Myall KJ, Norton S, Birring SS, Galloway J. Bechman K, et al. Among authors: adas m. Lancet Reg Health Eur. 2025 Apr 4;53:101283. doi: 10.1016/j.lanepe.2025.101283. eCollection 2025 Jun. Lancet Reg Health Eur. 2025. PMID: 40247851 Free PMC article.
Abatacept and the risk of malignancy: a meta-analysis across disease indications.
Zuckerman BP, Gibson M, Roy R, Hughes M, Mehta D, Yang Z, Adas M, Ng K, Russell MD, Cope A, Norton S, Galloway J. Zuckerman BP, et al. Among authors: adas m. Rheumatology (Oxford). 2025 Jun 1;64(6):3280-3287. doi: 10.1093/rheumatology/keaf114. Rheumatology (Oxford). 2025. PMID: 39992258 Free PMC article.
The infection risks of JAK inhibition.
Adas MA, Alveyn E, Cook E, Dey M, Galloway JB, Bechman K. Adas MA, et al. Expert Rev Clin Immunol. 2022 Mar;18(3):253-261. doi: 10.1080/1744666X.2022.2014323. Epub 2021 Dec 29. Expert Rev Clin Immunol. 2022. PMID: 34860621 Free PMC article.
Rising rates of sepsis in England: an ecological study.
Allen VB, Bechman K, Russell MD, Adas MA, Goodman AL, McPhail MJ, Norton S, Galloway JB. Allen VB, et al. Among authors: adas ma. Infection. 2025 Dec;53(6):2601-2612. doi: 10.1007/s15010-025-02601-0. Epub 2025 Jul 15. Infection. 2025. PMID: 40663286 Free PMC article.
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Yates M, Mootoo A, Adas M, Bechman K, Rampes S, Patel V, Qureshi S, Cope AP, Norton S, Galloway JB. Yates M, et al. Among authors: adas m. Arthritis Rheumatol. 2021 May;73(5):779-788. doi: 10.1002/art.41580. Epub 2021 Mar 25. Arthritis Rheumatol. 2021. PMID: 33174384
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis.
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S. Qureshi S, et al. Among authors: adas m. RMD Open. 2026 Feb 11;12(1):e006368. doi: 10.1136/rmdopen-2025-006368. RMD Open. 2026. PMID: 41672721 Free PMC article.
47 results